The total return over the past 12 months is -13.37% vs. +16.94% for the S&P 500. So far it's up +52.69% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (13.37%) | +25.68% | (8.73%) | N/A | N/A | N/A |
| Total Return CAGR | (13.37%) | +25.68% | (8.73%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
ORIC Pharmaceuticals, Inc. (ORIC)
| Year | Start price | End price | ORIC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $8.18 | $12.49 | +52.69% | +14.51% | +38.18% |
| 2025 | $8.07 | $8.18 | +1.36% | +17.72% | (16.36%) |
| 2024 | $9.20 | $8.07 | (12.28%) | +24.89% | (37.17%) |
| 2023 | $5.89 | $9.20 | +56.20% | +26.19% | +30.01% |
| 2022 | $14.70 | $5.89 | (59.93%) | (18.17%) | (41.76%) |
| 2021 | $33.85 | $14.70 | (56.57%) | +28.74% | (85.31%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
